Merck & Co Inc at JPMorgan Healthcare Conference Transcript
Good afternoon, everybody. I'm Chris Schott at JPMorgan. It's my pleasure to be introducing Merck today.
From the company, we have CEO, Rob Davis; as well as Dean Li, President of Merck Research Labs. Rob and Dean will say a lot to go through. Happy New Year. Looking forward to the presentation.
Thank you. Thanks, Chris. Appreciate it.
All right. Good afternoon, everybody. I appreciate you spending some time with us this afternoon.
Before I get started, just real quickly, I'd remind you that we do have forward-looking statements being made. I'd point you to our language on our website, if you'd like more information about that.
If you look at where we are as Merck, I'm pleased to say we are in a moment where we're really starting to see our transformation underway. We've been executing on our strategy. I can tell you, we're in a position now where I think we are well positioned
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
